Biomorph Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 23-10-2024
- Paid Up Capital ₹ 0.50 M
as on 23-10-2024
- Company Age 10 Year, 20 Days
- Last Filing with ROC 31 Mar 2023
- Revenue -28.77%
(FY 2023)
- Profit -25.56%
(FY 2023)
- Ebitda -13.65%
(FY 2023)
- Net Worth 16.10%
(FY 2023)
- Total Assets -3.16%
(FY 2023)
About Biomorph Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Dharinder Vashishta and Lalit Raj serve as directors at the Company.
- CIN/LLPIN
U24232CH2014PTC035317
- Company No.
035317
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biomorph Lifesciences Private Limited offer?
Biomorph Lifesciences Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Malaria Medicine, Sexual Wellness Products, Fertility Enhancer, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Nutraceuticals & Dietary Supplements, Fitness Supplements, Brain & Nervous System Drugs.
Who are the key members and board of directors at Biomorph Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharinder Vashishta  | Director | 12-Dec-2014 | Current |
| Lalit Raj | Director | 24-Nov-2022 | Current |
Financial Performance of Biomorph Lifesciences.
Biomorph Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.77% decrease. The company also saw a substantial fall in profitability, with a 25.56% decrease in profit. The company's net worth Soared by an impressive increase of 16.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biomorph Lifesciences?
Unlock access to Biomorph Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sharma Engineering Corporation Pvt LtdActive 63 years 1 monthDharinder Vashishta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biomorph Lifesciences?
Unlock and access historical data on people associated with Biomorph Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biomorph Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biomorph Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
